<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Schlattner 2006&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Schlattner 2006"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Schlattner 2006</h1><p class="article date">2020-10-23</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/2540216 target=_blank>Sciwheel</a></p><p><a href=https://www.sciencedirect.com/science/article/pii/S092544390500133X target=_blank>Article</a><sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><h2 id=introduction>Introduction</h2><ul><li>Creatine kinase (CK) is a central controller of cellular energy homeostasis: PCr + ADP &lt;=> Cr + ATP</li></ul><h2 id=mitochondrial-creatine-kinase-mtck-an-enzyme-central-to-cellular-energetics>Mitochondrial creatine kinase (mtCK) —an enzyme central to cellular energetics</h2><p><img src=https://user-images.githubusercontent.com/40054455/86718653-dfefa880-c055-11ea-80e2-186debe864f6.png alt=fig1></p><ul><li>@ cristae and intermembrane space</li><li>phosphocreatine: buffer</li><li>(In the cmpartments) metabolite channeling or functional coupling<ul><li>high local [ATP]/[ADP] ratios in the vicinity of cellular ATPases</li><li>low at ATP synthase</li></ul></li></ul><h2 id=dual-localization-of-creatine-kinase-microcompartments-in-mitochondria>Dual localization of creatine kinase microcompartments in mitochondria</h2><p><img src=https://user-images.githubusercontent.com/40054455/86718661-e1b96c00-c055-11ea-9b8f-5ae4be24db36.png alt=fig2></p><ul><li>IMS is a microcompartment for adenylates<ul><li>IMS height = 9nm. (Could fit mtCK octamer)</li><li>Cristae junctions (pendiculi) &lt;= 10–15 nm</li><li>VDAC is a rate-limiting diffusion barrier</li></ul></li></ul><h2 id=mtck-proteolipid-complexes-in-contact-sites>MtCK proteolipid complexes in contact sites</h2><ul><li>channeling of ‘‘high-energy’’ phosphates, regulated by the energy state</li><li>Proteolipid complexes<ul><li>adenine translocator (ANT) in IMM</li><li>VDAC in OMM</li><li>Kinases (e.g. mtCK, NDP kinase @ IMS, mtHK @ OMM)</li><li>apoptotic proteins: cyt c, Bcl-2,</li><li>protective effect on mitochondrial permeability transition (MPT)</li></ul></li><li>Only octameric MtCK shows a high affinity to cardiolipin and other anionic phospholipids and stucks in the membrane</li><li>Calcium is yet another signal that seems to regulate MtCK complexes</li></ul><h2 id=function-of-mtck-proteolipid-complexes-in-metabolite-channeling-and-apoptosis>Function of MtCK proteolipid complexes in metabolite channeling and apoptosis</h2><ul><li>Streamlined metabolite exchange (fusing rxn of VDAC, mtCK, & ANT): ATP(m) + Cr(i) &lt;=> ADP(m) + PCr(i)</li><li>The degree of such metabolite channeling seems to vary among different tissues, species, and developmental states</li><li>MtCK could play the role of an energy sensor, coupling cellular energy state to programmed cell death</li></ul><h2 id=mitochondrial-creatine-kinasefrom-molecular-damage-to-pathological-states>Mitochondrial creatine kinase—from molecular damage to pathological states</h2><h3 id=mtcka-prime-target-of-oxidative-and-radical-induced-molecular-damage>MtCK—a prime target of oxidative and radical-induced molecular damage</h3><ul><li>All CK isoenzymes are extremely susceptible to damage by ROS and RNS (superoxide anions (O2-), hydrogen peroxide (H2O2), hydroxyl radicals (OH), nitrogen monoxide (NO) and peroxynitrite (PN, ONOO*)</li><li>Mitochondrial ROS can also be generated by pharmacological interventions, e.g., with <strong>anthracyclines</strong>, a prominent class of anti-cancer drugs</li><li>Enzyme inactivation (active site) & interfere with oligomeric state and membrane binding capacity of mtCK (dimer/dimer interface)</li><li>CK inactivation is irreversible, especially at higher ROS concentrations<ul><li>MtCK is particularly susceptible to PN treatment (μM range)</li><li>sMtCK (heart, muscle) octamers are more susceptible to PN than those of uMtCK (brain)
<img src=https://user-images.githubusercontent.com/40054455/86718683-e67e2000-c055-11ea-88ec-d01e89d2801b.png alt=fig3></li></ul></li></ul><h3 id=impairment-of-mtck-in-ischemia-and-cardiomyopathy>Impairment of MtCK in ischemia and cardiomyopathy</h3><ul><li>&ldquo;stability paradox&rdquo; in heart: metabolic homeostasis despite large fluctuations in work load<ul><li>Relies on CK shuttle running by mtCK, esp. sMtCK (sMtCK isoenzyme can make up to 25% of total CK activity in rat heart)</li><li>mitochondrial volume ~40% of cellular volume</li><li>Lack in Cr or mtCK => reduced performance and cardiomyopathy in KO rats</li></ul></li><li>vicious cycle from ROS: ischemia/reperfusion injury => increased ROS => inactivation of mtCK => less cytosolic ATP => Ca overload => more ROS/RNS => &mldr; => mitochondrial permeability transition, apoptosis and/or necrosis</li><li>ischemic preconditioning => protection to sMtCK and ANT complex => higher energy flux through CK</li></ul><h3 id=involvement-of-mtck-in-anthracycline-induced-cardiotoxicity>Involvement of MtCK in anthracycline-induced cardiotoxicity</h3><ul><li>severe acute and chronic cardiotoxicity still represent serious complications of anthracycline (e.g. doxorubicin) therapy</li><li>oxidative damage and functional impairment of MtCK in a dose-, time-, and drug-dependent manner in vitro and in vivo</li><li>MtCK as well as ANT are preferentially hit by the drug (competition for cardiolipin)</li><li>10–30μM doxorubicin complexed with iron induced sMtCK inactivation within several tens of minutes</li><li>Dimerization and inhibition of sMtCK membrane binding could also destabilize mitochondrial contact sites</li><li>Organs that lack MtCK (liver) or express high levels of uMtCK (e.g., kidney and brain) do not show severe anthracycline toxicity</li></ul><h3 id=impairment-of-mtck-in-neurodegenerative-disorders>Impairment of MtCK in neurodegenerative disorders</h3><ul><li>ROS => inactivation of uMtCK in the brain</li><li>uMtCK inacitvation observed in AD and ALS</li><li>Creatine supplementation?</li></ul><h2 id=up-regulation-of-mitochondrial-creatine-kinase-in-human-health-and-disease>Up-regulation of mitochondrial creatine kinase in human health and disease</h2><ul><li>sMtCK expression follows the simultaneous induction of mitochondria,</li><li>in situations of high aerobic workload, the energy transport function of sMtCK is important</li><li>up-regulation of the mitochondrial transcription factor A (mtTFA) => expression of sMtCK</li><li>Creatine depletion by β-GPA feeding => energy cirsis => crystalline inclusions (mtCK) in the mitochondria due to compensatory overexpression. Also seen in mitochondrial cytopathies.
<img src=https://user-images.githubusercontent.com/40054455/86718701-e8e07a00-c055-11ea-867c-db391f0da8b9.png alt=fig4></li><li>Overexpression of uMtCK in cancer (protection against apoptosis)</li></ul><h2 id=reference>Reference</h2><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta 2006;1762(2):164-180. doi:10.1016/j.bbadis.2005.09.004. <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/scialo-2016/><span class="iconfont icon-article"></span>Scialo 2016</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/sazanov-1994/><span class="iconfont icon-article"></span>Sazanov 1994</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>